DOI: http://dx.doi.org/10.18203/2394-6040.ijcmph20211777

Clinico-demographic profile of deceased patients with coronavirus disease in a tertiary care centre of central India

Rupali A. Patle, Ashok R. Jadhao, Priya B. Dhengre, Manjusha A. Dhoble

Abstract


Background: The covid pandemic started from Hubei, Wuhan in December 2020 then covered many other countries including India. Understanding the demographic and clinical characteristics of deceased COVID-19 patients could inform public health interventions focusing on preventing mortality due to COVID-19. The present study was done with the objective of studying the socio-demographic and clinical profile of deceased patients with coronavirus disease.

Methods: This is a hospital based cross-sectional study on 1190 deceased patients of coronavirus disease in a tertiary care hospital of central India which is a dedicated covid hospital from 11 March 2020 to 28 February 2021. Socio-demographic and clinical characteristics of deceased patients were recorded.

Results: Overall case fatality rate was 13.24%. Maximum number of deaths occurred in the month of August 2020 and September 2020 were 372 (31.26%) and 477 (40.08%). It was higher in the males 791 (66.47%) as compared to females 399 (33.53%), but the difference was not significant. The most common symptom was fever on hospitalization 924 (77.65%), followed by generalized weakness 771 (64.79%). 352 (29.58%) patients died within 24 hours of the admission to hospital. Hypertension and type 2 diabetes mellitus were the most prevalent morbidity in 557 (46.80%) and 357 (30.00%). It was found that 232 (19.50%) deceased patients had oxygen saturation less than 50% on admission.

Conclusions: Higher age and presence of co-morbidities at the time of admission were significantly associated with mortality.


Keywords


COVID-19, Deaths, Coronavirus, Comorbidities, Symptoms, Duration of stay

Full Text:

PDF

References


Purcell LN, Charles AG. An invited commentary on World Health Organization declares global emergency: a review of the 2019 novel coronavirus (COVID- 19)": emergency or new reality? Int J Surg. 2020;76:111.

Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054-62.

Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun. 2020;109:102433.

Tambe MP, Parande MA, Tapare VS, Borle PS, Lakde RN, Shelke SC. An epidemiological study of laboratory confirmed COVID-19 cases admitted in a tertiary care hospital of Pune, Maharashtra. Ind J Pub Heal. 2020;64(6):183-6.

GOM. DMER, MEDD. Report of Covid 19 cases. Analytics: Medical Education and Drugs Department. Data: Public Health Department. 2021. http://www.dmer.org/new/MEDD%20REPORT%2028-02-2021.pdf. Last accessed on 9th March, 2021.

The Hindu. Fact sheet: Imperatives after India’s September virus peak, 2020. Available at: https://www.thehindu.com/opinion/lead/imperatives-after-indias-september-virus-peak/article32719000.ece. Accessed on 3 March 2021.

One of the highest globally, India’s Recovery Rate now nearly 97%, Press Information Bureau. 2021 https://www.thehinducentre.com/resources/article33682695.ece/binary/PIB1692852.pdf. Last accessed on 2 February, 2021.

Ghosh AA, Nundy SB, Mallick TK. How India is dealing with COVID-19 pandemic. Sensors International. 2020;1:100021.

Zaim S, Chong JH, Sankaranarayanan V, Harky A. COVID-19 and Multiorgan Response. Curr Probl Cardiol. 2020;45(8):100618.

Renu K, Prasanna PL, Valsala Gopalakrishnan A. Coronaviruses pathogenesis, comorbidities and multi-organ damage: a review. Life Sci. 2020;255:117839.

Soni SL, Kajal K, Yaddanapudi LN, Malhotra P, Puri GD, Bhalla A, et al. Demographic and clinical profile of patients with COVID-19 at a tertiary care hospital in north India. Indian J Med Res. 2020.

Singhal T. A review of coronavirus disease-2019 (COVID-19). Indian J. Pediatr. 2020;87(4):281-6.

Ministry of Health and Family Welfare. Adequate health infrastructure and health facilities set up for COVID-19management. PIB Delhi. 2020. https://www.mohfw.gov.in/pdf/FinalGuidanceonMangaementofCovidcasesversion2.pdf. Last accessed on 23 February, 2021.

Asirvatham ES, Sarman CJ, Saravanamurthy SP, Mahalingam P, Maduraipandian SE, Lakshmanan J. Who is dying from COVID-19 and when? An Analysis of fatalities in Tamil Nadu, India. Clinic Epidemiol Glob Heal. 2021;9:275-9.

Chen T, Wu D, Chen H, Yan W, Yang D, Chen G, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ. 2020;368:1091.

Mueller AL, McNamara MS, Sinclair DA. Why does COVID-19 disproportionately affect older people? Aging. 2020;12(10):9959-81.

Verity R, Okell LC, Dorigatti I, Winskill P, Whittaker C, Imai N, et al. Estimates of the severity of coronavirus disease 2019: a model-based analysis. Lancet Infect Dis. 2020;20(6):669-77.

Li Y, Jerkic M, Slutsky AS, Zhang H. Molecular mechanisms of sex bias differences in COVID-19 mortality. Crit Care. 2020;24(1):405.

National IIPS. Family Health Survey-2017 (NFHS-4). New Delhi: Ministry of Heallth and Family Welfare, Government of India. 2017. http://rchiips.org/nfhs/nfhs-4Reports/India.pdf. Last accessed 25 February, 2021

Guan W, Liang W, Zhao Y, Liang H, Chen Z, Li Y, et al. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur Respir J. 2020;55(5):2000547.

Chen J, Qi T, Liu L, Ling Y, Qian Z, Li T, et al. Clinical progression of patients with COVID-19 in Shanghai, China. J Infect. 2020;80(5):1-6.

Giacomelli A, Ridolfo AL, Milazzo L, Oreni L, Bernacchia D, Siano M, et al. 30-day mortality in patients hospitalized with COVID-19 during the first wave of the Italian epidemic: a prospective cohort study. Pharmacol Res. 2020;158:104931.

CDC. Severe Outcomes among patients with coronavirus disease 2019 (COVID-19): United States, February 12-March 16, 2020. Morb Mortal Wkly Rep. 2020;69(12):343-6.

Mueller AL, McNamara MS, Sinclair DA. Why does COVID-19 disproportionately affect older people? Aging (Albany NY). 2020;12(10):9959-81.

Liu H, Chen S, Liu M, Nie N Lu H. Comorbid chronic diseases are strongly correlated with disease severity among COVID-19 patients: a systematic review and meta-analysis. Aging Dis. 2020;11(3):668-78.

Sanyaolu A, Okorie C, Marinkovic A, Patidar R, Younis K, Desai P, et al. Comorbidity and its impact on patients with COVID-19. SN Compr Clin Med. 2020:1-8.

Grant MC, Geoghegan L, Arbyn M, Mohammed Z, McGuinness L, Clarke EL, et al. The prevalence of symptoms in 24,410 adults infected by the novel coronavirus (SARS-CoV-2; COVID-19): a systematic review and meta-analysis of 148 studies from 9 countries. PloS One. 2020;15(6):0234765.

Xie J, Covassin N, Fan Z, Singh P, Gao W, Li G, et al. Association between hypoxemia and mortality in patients with COVID-19. Mayo Clin Proc. 2020;95:1138-47.

Mejıa F, Medina C, Cornejo E, Morello E, Vasquez S, Alave J, et al. Oxygen saturation as a predictor of mortality in hospitalized adult patients with COVID-19 in a public hospital in Lima, Peru. PLoS One. 2020;15(12).

Qiu P, Zhou Y, Wang F, Wang H, Zhang M, Pan X, et al. Clinical characteristics, laboratory outcome characteristics, comorbidities, and complications of related COVID-19 deceased: a systematic review and meta-analysis. Aging Clin Exp Res. 2020;32(9):1869-78.